vimarsana.com

Delcath Systems (NASDAQ:DCTH – Get Free Report) was upgraded by analysts at StockNews.com to a “sell” rating in a report issued on Tuesday. A number of other equities research analysts have also recently weighed in on the company. BTIG Research increased their price target on Delcath Systems from $19.00 to $20.00 and gave the company […]

Related Keywords

United States ,John Purpura ,Roth Mkm ,Canaccord Genuity Group ,Vivo Capital ,Securities Exchange Commission ,Rosalind Advisors Inc ,Armistice Capital ,Stonepine Capital Management ,Capital Partners ,Delcath Systems Company Profile ,Delcath Systems Inc ,Tower Research Capital ,Delcath Systems ,Get Free Report ,Genuity Group ,Director Rosalind Advisors ,Exchange Commission ,Research Capital ,Capital Management ,Delcath Systems Daily ,Nasdaq Dcth ,Cdcth ,Medical ,Upgrade ,Stocknews Com ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.